Literature DB >> 7603428

Pertussis--United States, January 1992-June 1995.

.   

Abstract

Pertussis was a major cause of morbidity and mortality among infants and children in the United States during the prevaccine era (i.e., before the mid-1940s). Since pertussis became a nationally reportable disease in 1922, the highest number of pertussis cases (approximately 260,000) was reported in 1934; the highest number of pertussis-related deaths (approximately 9000) occurred in 1923. Following the licensure of whole-cell pertussis vaccine combined with diphtheria and tetanus toxoids (DTP) in 1949 and the widespread use of DTP among infants and children, the incidence of reported pertussis declined to a historical low of 1010 cases in 1976 (Figure 1). However, since the early 1980s, reported pertussis incidence has increased cyclically with peaks occurring in 1983, 1986, 1990, and 1993 (1-3). This report summarizes national surveillance data for pertussis from January 1992 through June 1995 from CDC's National Public Health Surveillance System (NPHSS) and Supplementary Pertussis Surveillance System (SPSS) and assesses the effectiveness of pertussis vaccination in the United States during this period using vaccination coverage data from CDC's National Health Interview Survey (NHIS).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7603428

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  19 in total

Review 1.  The Bordetella pertussis model of exquisite gene control by the global transcription factor BvgA.

Authors:  Kimberly B Decker; Tamara D James; Scott Stibitz; Deborah M Hinton
Journal:  Microbiology       Date:  2012-05-24       Impact factor: 2.777

2.  Infection of newborn piglets with Bordetella pertussis: a new model for pertussis.

Authors:  S Elahi; R Brownlie; J Korzeniowski; R Buchanan; B O'Connor; M S Peppler; S A Halperin; S F Lee; L A Babiuk; V Gerdts
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

Review 3.  Diagnosis and management of pertussis.

Authors:  Alberto E Tozzi; Lucia Pastore Celentano; Marta Luisa Ciofi degli Atti; Stefania Salmaso
Journal:  CMAJ       Date:  2005-02-15       Impact factor: 8.262

Review 4.  Childhood immunisation today.

Authors:  J Eskola
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

5.  Toward safer and more efficient pertussis vaccines.

Authors:  A Wegmann; R Glück
Journal:  Eur J Pediatr       Date:  1996-02       Impact factor: 3.183

Review 6.  Licensed pertussis vaccines in the United States. History and current state.

Authors:  Nicola P Klein
Journal:  Hum Vaccin Immunother       Date:  2014-11-06       Impact factor: 3.452

7.  Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge model.

Authors:  J B Bruss; G R Siber
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

Review 8.  Which strategy for pertussis vaccination today?

Authors:  Dorota Z Girard
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  Improved efficacy of a licensed acellular pertussis vaccine, reformulated in an adjuvant emulsion of liposomes in oil, in a murine model.

Authors:  Marc Mansour; Robert G Brown; Annette Morris; Bruce Smith; Scott A Halperin
Journal:  Clin Vaccine Immunol       Date:  2007-08-22

10.  The distribution over time of costs and social net benefits for pertussis immunization programs.

Authors:  Dorota Zdanowska Girard
Journal:  Int J Health Care Finance Econ       Date:  2009-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.